Yaz Blamed For 23 Deaths

Yaz Birth Control Blamed In 23 Deaths

Yaz birth control is being blamed in 23 deaths. Yaz and Yasmin are suspected of causing blood clots which can lead to sudden and unexpected death.

The documentation, provided by Health Canada, includes reports from medical doctors and pharmacists. The documentation is part of a class-action lawsuit filed against Bayer, who manufactured the birth control pills.

As reported by CBC, Yaz and Yasmin birth control pills contain drospirnone, which is a synthetic hormone. Drospirone is used exclusively in Yasmin and Yaz birth control. The “newer-generation” birth control offers a reduction is symptoms associated with a menstrual cycle, which appeals to many women. Unfortunately, numerous women also experienced adverse side effects, including death.

Canada Health issued a warning in 2011, stating that birth control containing Drospirone may increase chances of developing blood clots. The health organization collected documentation indicating that more than 600 women experienced adverse side-effects. Additionally, Yasmin and Yaz are blamed in 23 deaths.

Attorney Tony Merchant is representing over 1,000 clients in the Canadian class-action lawsuit against Bayer. He has stated that the number of adverse reactions and deaths may be under reported. As reported by Global News, Merchant has suggested that Bayer was aware of the increased risk for adverse reactions.

Women in Canada and the United States have complained of serious side-effects and adverse reactions to Yaz or Yasmin.

In the US, Bayer was ordered to pay nearly $1 billion to women who experienced blood clots, which eventually led to heart attacks and strokes. Additionally, women suffering with gall bladder damage were awarded up to $3,000 each.

The US Food and Drug Administrations issued numerous warnings to Bayer, citing misleading advertising. Currently, the law firm of Page Bradley has announced a class-action lawsuit claiming that Bayer continues to misrepresent Yaz birth control in advertisements.

As reported by PR Web, Bradley has stated that she and her firm are “disturbed by the idea that the makers of Yaz were more concerned about painting a pretty picture in their advertisements… than they were about the safety and health of their customer.”

Bayer denies all claims that they were aware of increased adverse reactions. They state that customer safety remains their first priority.

Despite the denial, Yasmin and Yaz are blamed in 23 deaths. The Canadian trial will begin in September in Ontario.

Comments